Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Pharmaceutical Solution Industries (PSI) is a prominent pharmaceutical manufacturing company headquartered in Jeddah, Saudi Arabia. Founded in 1978, the company specializes in the production of sterile intravenous (IV) solutions, hemodialysis concentrates, and small-volume parenterals. PSI serves as a critical supplier to the healthcare sector in the Middle East and North Africa (MENA) region, operating facilities that comply with international Good Manufacturing Practice (GMP) standards. Their product range includes essential fluids such as sodium chloride, dextrose, and Ringer's lactate, as well as specialized irrigation solutions. As a subsidiary of Banaja Holdings, PSI continues to expand its manufacturing capacity to meet the growing regional demand for high-quality injectable medications. The company utilizes advanced technologies like Blow-Fill-Seal (BFS) to ensure the sterility and safety of its products.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Pharmaceutical Solution Industries.